D L Glaubiger
Overview
Explore the profile of D L Glaubiger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Glaubiger D, Casler J, Garrett W, Yuo H
Cancer
. 1991 Oct;
68(8):1828-31.
PMID: 1913528
The case of a 57-year-old man with chondrosarcoma of the laryngeal cartilage is presented, occurring 16 years after radiation treatment for squamous cell carcinoma of the right true vocal cord....
2.
Young M, Kinsella T, Miser J, Triche T, Glaubiger D, Steinberg S, et al.
Int J Radiat Oncol Biol Phys
. 1989 Jan;
16(1):49-57.
PMID: 2643597
As part of two sequential protocols using intensive combined modality treatment in pediatric and adolescent sarcomas, 31 consecutive patients with primary chest wall tumors were treated between November 1977 and...
3.
Holcenberg J, Tutsch K, Earhart R, Ungerleider R, Kamen B, Pratt C, et al.
Cancer Treat Rep
. 1986 Jun;
70(6):703-9.
PMID: 3089595
A phase I study of ICRF-187 as a 2-hour iv infusion daily for 3 days was conducted in 46 evaluable pediatric patients. The maximum tolerated dose was 3500 mg/m2/day X...
4.
Ungerleider R, Pratt C, Vietti T, Holcenberg J, Kamen B, Glaubiger D, et al.
Cancer Treat Rep
. 1985 Apr;
69(4):403-7.
PMID: 3857968
Mitoxantrone was administered as a single iv injection once every 3 weeks to 84 children with advanced acute leukemia and solid tumors in a phase I trial. Dose-limiting granulocytopenia occurred...
5.
Gangji D, Ross W, Bleyer W, Poplack D, Glaubiger D
Cancer Treat Rep
. 1984 Mar;
68(3):521-5.
PMID: 6704981
The effect of probenecid on methotrexate cytotoxicity has been measured using mouse L1210 leukemia cells in vitro. Cytotoxic effects were measured using a soft agar cloning technique. Cell exposure to...
6.
McKeen E, Hanson M, Mulvihill J, Glaubiger D
N Engl J Med
. 1983 Dec;
309(24):1522.
PMID: 6646179
No abstract available.
7.
Johnson G, Glaubiger D
Cancer Treat Rep
. 1983 Feb;
67(2):163-8.
PMID: 6825124
No abstract available.
8.
Dwyer A, Glaubiger D, Ecker J, Doppman J, Prewitt J, Plunkett J
Radiology
. 1982 Nov;
145(2):327-31.
PMID: 7134429
An analysis of the patterns of detectable tumor recurrence using the concepts of hazard rate, predictive value, and cumulative probability was undertaken to assess the appearance of metastases in Ewing...
9.
Friedman H, Glaubiger D
Cancer Res
. 1982 Nov;
42(11):4683-9.
PMID: 7127304
We have developed a method for performing in vitro drug testing on primary human tumor explants which is a variant of the human tumor stem cell assay (HTSCA) described previously...
10.
Srinivasan U, Reaman G, Poplack D, Glaubiger D, Levine A
Am J Clin Oncol
. 1982 Aug;
5(4):411-5.
PMID: 6180626
Eight patients with osteogenic sarcoma and seven patients with Ewing's sarcoma, all with advanced metastatic disease refractory to conventional therapy, were treated with 5-azacytidine (NSC-102816) intravenously at a dosage of...